Competition may also influence brand manufacturers to offer discounts or patient support programs
Remission of type 2 diabetes with very low-calorie dietsA
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1864 (11), 2015-2025
That said, its important to note that compounded GLP-1 medications are not FDA-approved as finished products
Long-term impact on total cost of care also remains to be seen. Whats more, at $11,500-$14,000 annual wholesale acquisition price for GLP-1a weight loss treatment, the Institute for Clinical Economic Review (ICER) cost-effectiveness analysis identified that GLP-1a weight loss therapies are over-priced two-fold to their expected value in weight loss associated reduction in cardiovascular events and diabetes development avoidance over a lifetime
Not only for people who work out, but also for those with specific health concerns